Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery
Clinical trial NCT03405155 · COMPLETED
Trial details
- NCT number
- NCT03405155
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-17
- Primary completion
- 2025-12-15
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.